145 related articles for article (PubMed ID: 29896272)
1. Genomic and epigenetic signatures associated with survival rate in oral squamous cell carcinoma patients.
Ribeiro IP; Caramelo F; Esteves L; Oliveira C; Marques F; Barroso L; Melo JB; Carreira IM
J Cancer; 2018; 9(11):1885-1895. PubMed ID: 29896272
[No Abstract] [Full Text] [Related]
2. WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.
Ribeiro IP; Caramelo F; Marques F; Domingues A; Mesquita M; Barroso L; Prazeres H; Julião MJ; Baptista IP; Ferreira A; Melo JB; Carreira IM
Cell Oncol (Dordr); 2016 Dec; 39(6):573-582. PubMed ID: 27491556
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours.
Agundez M; Grau L; Palou J; Algaba F; Villavicencio H; Sanchez-Carbayo M
Eur Urol; 2011 Jul; 60(1):131-40. PubMed ID: 21514719
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification of non-muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes.
Sacristan R; Gonzalez C; Fernández-Gómez JM; Fresno F; Escaf S; Sánchez-Carbayo M
J Mol Diagn; 2014 Sep; 16(5):564-572. PubMed ID: 24998186
[TBL] [Abstract][Full Text] [Related]
6. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Moelans CB; Verschuur-Maes AH; van Diest PJ
J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma.
Mžik M; Chmelařová M; John S; Laco J; Slabý O; Kiss I; Bohovicová L; Palička V; Nekvindová J
Clin Chem Lab Med; 2016 Dec; 54(12):1971-1980. PubMed ID: 27171388
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.
Livide G; Epistolato MC; Amenduni M; Disciglio V; Marozza A; Mencarelli MA; Toti P; Lazzi S; Hadjistilianou T; De Francesco S; D'Ambrosio A; Renieri A; Ariani F
Pathol Oncol Res; 2012 Jul; 18(3):703-12. PubMed ID: 22278416
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic, genomic, and epigenetic characterization of the HSC-3 tongue cell line with lymph node metastasis.
Ribeiro IP; Rodrigues JM; Mascarenhas A; Kosyakova N; Caramelo F; Liehr T; Melo JB; Carreira IM
J Oral Sci; 2018 Mar; 60(1):70-81. PubMed ID: 29479029
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients.
Ghantous Y; Nashef A; Abu-Elnaaj I
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32272578
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
14. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
15. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
16. Genomic and epigenetic characterization for the comparison of synchronous bilateral tongue squamous cell carcinomas-A case report.
Ribeiro IP; Barroso L; Marques F; Santos A; Caramelo F; Julião MJ; Melo JB; Carreira IM
Curr Probl Cancer; 2017; 41(6):398-406. PubMed ID: 29056289
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic methylation changes: implication as biomarkers in oral and maxillofacial area cancers.
Aghiorghiesei O; Irimie AI; Braicu C; Raduly L; Nutu A; Balint E; Mehterov N; Vladimirov B; Sarafian V; Lucaciu O; Campian R; Berindan-Neagoe I
Med Pharm Rep; 2023 Jul; 96(3):310-317. PubMed ID: 37577021
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
